Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas
מצבים רפואיים
BRAF V600 Mutation · Low-grade Glioma · Low Grade Glioma of Brain · Recurrent Low Grade Glioma
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
University of Alabama at Birmingham, Birmingham, Alabama, United States
Contact: Study coordinator (Girish Dhall, MD)Contact: Principal Investigator (Girish Dhall, MD)University of California, San Francisco, San Francisco, California, United States
Contact: Principal Investigator (Sabine Mueller, MD, PhD, MAS)John Hopkins Medical Center, Baltimore, Maryland, United States
Contact: Principal Investigator (Kenneth Cohen, MD, MBA)St. Louis Children's Hospital Washington University in St. Louis, St Louis, Missouri, United States
Contact: Principal Investigator (Mohamed S Abdelbaki, MD)Duke University Medical Center, Durham, North Carolina, United States
Contact: Study coordinator (Daniel Landi, MD)Contact: Principal Investigator (Daniel Landi, MD)St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Contact: Principal Investigator (Amar Gajjar, MD)University of Utah, Salt Lake City, Utah, United States
Contact: Study coordinator (Nicholas Whipple, MD, MPH)Contact: Principal Investigator (Nicholas Whipple, MD, MPH)
מובילי המחקר
Sabine Mueller, MD, PHD
Principal Investigator
University of California, San Francisco